Insulin resistance is another suggested key factor in the development of T2DM that can be a consequence of obesity-induced inflammation (Wondmkun, 2020), resulting in a lack of sensitivity toward secreted insulin and elevated blood sugar levels, which are hallmarks of T2DM. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.